These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31692672)

  • 81. Statins redux: A re-assessment of how statins lower plasma cholesterol.
    Raghow R
    World J Diabetes; 2017 Jun; 8(6):230-234. PubMed ID: 28694924
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome.
    Sathyapalan T; Shepherd J; Arnett C; Coady AM; Kilpatrick ES; Atkin SL
    Clin Chem; 2010 Nov; 56(11):1696-700. PubMed ID: 20817794
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A pharmacoeconomic evaluation of statins in the treatment of hypercholesterolaemia in the primary care setting in Spain.
    Tárraga-López PJ; Celada-Rodríguez A; Cerdán-Oliver M; Solera-Albero J; Ocaña-López JM; López-Cara MA; De Miguel-Clave J
    Pharmacoeconomics; 2005; 23(3):275-87. PubMed ID: 15836008
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
    Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
    Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.
    Xu Y; Zhou S; Fang Z; Li X; Huang D; Liu Q; Zheng C
    Pharm Biol; 2014 Sep; 52(9):1196-203. PubMed ID: 25116077
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats.
    Li T; Wang D; Tian Y; Yu H; Wang Y; Quan W; Cui W; Zhou L; Chen J; Jiang R; Zhang J
    J Neurol Sci; 2014 Jun; 341(1-2):88-96. PubMed ID: 24774750
    [TBL] [Abstract][Full Text] [Related]  

  • 88. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Addressing the challenge.
    Olsson AG
    Eur Heart J; 1998 Oct; 19 Suppl M():M29-35. PubMed ID: 9821014
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus.
    Graham KL; Lee LY; Higgins JP; Steinman L; Utz PJ; Ho PP
    Arthritis Rheum; 2008 Jul; 58(7):2098-104. PubMed ID: 18576356
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.
    Nawrocki JW; Weiss SR; Davidson MH; Sprecher DL; Schwartz SL; Lupien PJ; Jones PH; Haber HE; Black DM
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):678-82. PubMed ID: 7749881
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of Orally Administered Atorvastatin on Plasma Lipid and Biochemistry Profiles in Hypercholesterolemic Hispaniolan Amazon Parrots (
    Robertson JA; Guzman DS; Graham JL; Stanhope KL; Douglas JM; Havel PJ; Beaufrère H; Knych H; Tully TN; Paul-Murphy JR
    J Avian Med Surg; 2020 Mar; 34(1):32-40. PubMed ID: 32237680
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of high-intensity statin therapy on steroid hormones and vitamin D in type 2 diabetic men: A prospective self-controlled study.
    Chihaoui M; Terzi A; Hammami B; Oueslati I; Khessairi N; Chaker F; Yazidi M; Feki M
    Lipids; 2024 Sep; 59(5):135-144. PubMed ID: 38764377
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS; Fong NT
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Effects of Administration of Vitamin D, Infliximab, and Leflunomide on Testosterone Concentrations in Rats under Atorvastatin Therapy.
    Aykan DA; Seyithanoglu M
    Eurasian J Med; 2019 Oct; 51(3):224-227. PubMed ID: 31692672
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W; Li WM; Gao C; Sun NL
    J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.